Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
about
Interactions between Myc and Mediators of Inflammation in Chronic Liver DiseasesClofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodentsRole of oxidative stress in the promoting activities of pcbs.Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressorSuppression of peroxisomal enzyme activities and cytochrome P450 4A isozyme expression by congeneric polybrominated and polychlorinated biphenyls.Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-kappaBInhibition of the promotion of hepatocarcinogenesis by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) by the deletion of the p50 subunit of NF-kappa B in mice.The Role of NF-kappaB in PPARalpha-Mediated Hepatocarcinogenesis.Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study.Nfkb1 suppresses DNA alkylation-induced tumor formation.The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice.
P2860
Q26778328-42A118CC-7ACB-49AA-9E16-13D3F0764C01Q28222350-E96F8F1B-8A0A-4B5B-963D-DA44D385160AQ33720806-DD2E5E63-F47D-40D1-B1E4-C58FF323311DQ34996082-9734E7F9-61C6-43B2-AD0B-DDCE0D639ADAQ36417508-76F0E634-C26E-4696-97C5-4FC59AF7B672Q36591837-B7C2D047-5958-4CE1-8CF7-850DAAE9D844Q36973163-0C9DAF84-2F91-4A78-93FF-C16B7E2E8F5FQ37078825-B6404191-6A72-4811-99ED-AB1C98C772CFQ38158164-6F4671E0-6C6B-4EAC-88B7-A4A912DD4AF0Q42084221-8AABACBB-82F6-4EC0-A12C-7F852DB6FB2AQ46249387-504DCB7C-7CF0-4F19-A600-FDA305EABF4BQ54719345-248C1D9F-AA43-41D0-AD7D-918836DD455E
P2860
Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@en
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@nl
type
label
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@en
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@nl
prefLabel
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@en
Inhibition of hepatocarcinogen ...... xisome proliferator Wy-14,643.
@nl
P2093
P2860
P356
P1476
Inhibition of hepatocarcinogen ...... oxisome proliferator Wy-14,643
@en
P2093
Aysegul Eyigor
Howard P Glauert
Job C Tharappel
Simon Cooper
P2860
P304
P356
10.1093/TOXSCI/KFJ116
P577
2006-01-24T00:00:00Z